Cardioselective beta blockade in hypertrophic cardiomyopathy.
D000293:Adolescent; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D006328:Cardiac Catheterization; D002302:Cardiac Output / Q000187:drug effects; D009202:Cardiomyopathies / Q000188:drug therapy*; D004983:Ethanolamines / Q000627:therapeutic use*; D005069:Evaluation Studies as Topic; D005260:Female; D006333:Heart Failure / Q000503:physiopathology; D006339:Heart Rate / Q000187:drug effects; D006352:Heart Ventricles / Q000503:physiopathology; D006801:Humans; D007275:Injections, Intravenous; D007545:Isoproterenol / Q000627:therapeutic use; D008875:Middle Aged; D005082:Physical Exertion; D011433:Propranolol / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D004983:Ethanolamines; D011433:Propranolol; D007545:Isoproterenol